Bioengineering a Unique Deimmunized Bispecific Targeted Toxin That Simultaneously Recognizes Human CD22 and CD19 Receptors in a Mouse Model of B-Cell Metastases

Overview of attention for article published in Molecular Cancer Therapeutics, June 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 21 patents that reference this research output.

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 17 additional patents.